AGAIN Stock Financial Analysis - Cloudia Research S.p.A. (BIT) Stock

Cloudia Research S.p.A.
IT ˙ BIT
€1.78 ↑0.02 (1.14%)
2025-09-05
SHARE PRICE
Overview
Cloudia Research S.p.A., based in Italy, is a prominent entity in the biotechnology sector, specializing in the development of advanced solutions for genetic engineering and molecular diagnostics. The company leverages state-of-the-art biotechnological methodologies to innovate in areas such as gene editing and synthetic biology. Key projects undertaken by Cloudia Research include the development of CRISPR-based therapies targeting rare genetic disorders and partnerships aimed at enhancing infectious disease diagnostics through next-generation sequencing technologies. These initiatives underline the company's commitment to pushing the boundaries of medical science and technology to contribute substantially to global health advancements.
Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income
  • The revenue for Cloudia Research S.p.A. as of December 31, 2024 is 8.90 MM.
  • The operating income for Cloudia Research S.p.A. as of December 31, 2024 is 0.61 MM.
  • The net income for Cloudia Research S.p.A. as of December 31, 2024 is 0.73 MM.
Period End (TTM) Revenue (MM) Operating Income (MM) Net Income (MM)
2024-12-31 8.90 0.61 0.73
2024-09-30 8.40 0.58 0.74
2024-06-30 7.91 0.51 0.75
2024-03-31 7.44 0.59 0.70
2023-12-31 6.98 0.70 0.65
2023-06-30 5.74 0.78 0.61
2023-03-31 5.05 0.71 0.55
2022-12-31 4.36 0.76 0.48
2021-12-31 2.21 0.24 0.12
Income Statement: EPS
Period End (TTM) Earnings Per Share Basic Earnings Per Share Diluted
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31 0.24 0.24
2023-06-30
2023-03-31
2022-12-31
2021-12-31
Cash Flow: Operations, Investing, Financing
  • The cash from operating activities for Cloudia Research S.p.A. as of December 31, 2024 is 0.61 MM.
  • The cash from investing activities for Cloudia Research S.p.A. as of December 31, 2024 is -2.14 MM.
  • The cash from financing activities for Cloudia Research S.p.A. as of December 31, 2024 is 0.79 MM.
Period End (TTM) Cash From Operating Activities (MM) Cash From Investing Activities (MM) Cash From Financing Activities (MM)
2024-12-31 0.61 -2.14 0.79
2024-09-30 0.77 -2.37 3.01
2024-06-30 0.93 -2.60 5.24
2024-03-31 1.14 -2.45 4.00
2023-12-31 1.35 -2.30 2.76
2023-06-30
2023-03-31
2022-12-31
2021-12-31
Valuation Metrics : PE, PriceToBook, PriceToTBV
  • The p/e for Cloudia Research S.p.A. as of December 31, 2024 is 13.07.
  • The p/book for Cloudia Research S.p.A. as of December 31, 2024 is 1.62.
  • The p/tbv for Cloudia Research S.p.A. as of December 31, 2024 is 2.82.
P/Book
The current closing price divided by the book value per share.
P/TBV
The current price divided by the tangible book value per share.
Period End (TTM) p/e P/Book P/TBV
2024-12-31 13.07 1.62 2.82
2024-09-30 13.07 1.62 2.82
2024-06-30 10.05 1.25 1.69
2024-03-31 9.97 2.45
2023-12-31 2.45
2023-06-30
2023-03-31
2022-12-31
2021-12-31
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
  • The ebit/ev for Cloudia Research S.p.A. as of December 31, 2024 is 0.04.
  • The ebit (3y)/ev for Cloudia Research S.p.A. as of December 31, 2024 is 0.04.
Period End (TTM) EBIT/EV EBIT (3y)/EV
2024-12-31 0.04 0.04
2024-09-30 0.04 0.05
2024-06-30 0.14 0.11
2024-03-31 0.14 0.10
2023-12-31 0.00 0.00
2023-06-30
2023-03-31
2022-12-31
2021-12-31
Management Effectiveness
  • The roa for Cloudia Research S.p.A. as of December 31, 2024 is 0.10.
  • The roe for Cloudia Research S.p.A. as of December 31, 2024 is 0.23.
  • The roic for Cloudia Research S.p.A. as of December 31, 2024 is 0.09.
  • The croic for Cloudia Research S.p.A. as of December 31, 2024 is 0.43.
  • The ocroic for Cloudia Research S.p.A. as of December 31, 2024 is 0.11.
Period End (TTM) ROA ROE ROIC CROIC OCROIC
2024-12-31 0.10 0.23 0.09 0.43 0.11
2024-09-30 0.10 0.23 0.09 0.43 0.11
2024-06-30 0.14 0.62 0.12 0.33 0.25
2024-03-31 0.17
2023-12-31 0.00
2023-06-30 0.25 1.51 0.23 -0.01 0.00
2023-03-31 0.23 1.36 0.25 -0.01 0.00
2022-12-31 0.00 0.00 0.00
2021-12-31 0.09 0.00 0.00
Gross Margins
  • The gross margin for Cloudia Research S.p.A. as of December 31, 2024 is 0.17.
  • The net margin for Cloudia Research S.p.A. as of December 31, 2024 is 0.09.
  • The operating margin for Cloudia Research S.p.A. as of December 31, 2024 is 0.06.
Gross Margin
The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
Net Margin
The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
Operating Margin
The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) Gross Margin Net Margin Operating Margin
2024-12-31 0.17 0.09 0.06
2024-09-30 0.16 0.10 0.07
2024-06-30 0.17 0.09 0.10
2024-03-31 0.26 0.10 0.17
2023-12-31
2023-06-30 0.26 0.10 0.17
2023-03-31 0.27 0.11 0.17
2022-12-31
2021-12-31 0.13 0.05 0.11
Identifiers and Descriptors
Central Index Key (CIK)
Industry Groups
Other Listings
DE:ZP2
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista